Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Aegis Analytical Corp.

Latest From Aegis Analytical Corp.

Medivation/Astellas’ Xtandi A Tough Rival For J&J’s Zytiga

Medivation/Astellas’ Xtandi was approved barely a month after FDA announced it had accepted its NDA for post-chemo castration-resistant metastatic prostate cancer, and the newly approved androgen blocker appears to have what it takes to unseat J&J’s market leader Zytiga.

BioPharmaceutical Comparative Effectiveness

On the Mark

Aventis and the German state of Hesse teamed up to create a public/private venture fund, in part to salve the political wounds of Hoechst's leaving its Frankfurt headquarters for Strasbourg, France. While any of its investments need to have a Hessen connection, the slowdown in the German VC boom makes this new fund a potentially important source of capital.
BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Diversified
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Aegis Analytical Corp.
  • Senior Management
  • John Darcy, Pres. & CEO
    Lauri H Larson, CFO
    Martin Wehr, VP, Bus. Dev.
    Steven W Wagner, VP, Sales
  • Contact Info
  • Aegis Analytical Corp.
    Phone: (303) 926-0317
    1376 Miners Drive
    Suite 106
    Lafayette, CO 80026